The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

被引:245
作者
Onizawa, Michio [1 ]
Oshima, Shigeru [1 ]
Schulze-Topphoff, Ulf [2 ]
Oses-Prieto, Juan A. [3 ]
Lu, Timothy [1 ]
Tavares, Rita [1 ]
Prodhomme, Thomas [2 ]
Duong, Bao [1 ]
Whang, Michael I. [1 ]
Advincula, Rommel [1 ]
Agelidis, Alex [1 ]
Barrera, Julio [1 ]
Wu, Hao [4 ]
Burlingame, Alma [3 ]
Malynn, Barbara A. [1 ]
Zamvil, Scott S. [2 ]
Ma, Averil [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[4] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; LINEAR POLYUBIQUITIN; PROGRAMMED NECROSIS; EXPRESSION; TNFAIP3; INFLAMMATION; REGULATOR; BINDING; RECOGNITION; DOWNSTREAM;
D O I
10.1038/ni.3172
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A20 is an anti-inflammatory protein linked to multiple human diseases; however, the mechanisms by which A20 prevents inflammatory disease are incompletely defined. We found that A20-deficient T cells and fibroblasts were susceptible to caspase-independent and kinase RIPK3-dependent necroptosis. Global deficiency in RIPK3 significantly restored the survival of A20-deficient mice. A20-deficient cells exhibited exaggerated formation of RIPK1-RIPK3 complexes. RIPK3 underwent physiological ubiquitination at Lys5 (K5), and this ubiquitination event supported the formation of RIPK1-RIPK3 complexes. Both the ubiquitination of RIPK3 and formation of the RIPK1-RIPK3 complex required the catalytic cysteine of A20's deubiquitinating motif. Our studies link A20 and the ubiquitination of RIPK3 to necroptotic cell death and suggest additional mechanisms by which A20 might prevent inflammatory disease.
引用
收藏
页码:618 / +
页数:11
相关论文
共 53 条
[1]   Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus [J].
Adrianto, Indra ;
Wen, Feng ;
Templeton, Amanda ;
Wiley, Graham ;
King, Jarrod B. ;
Lessard, Christopher J. ;
Bates, Jared S. ;
Hu, Yanqing ;
Kelly, Jennifer A. ;
Kaufman, Kenneth M. ;
Guthridge, Joel M. ;
Alarcon-Riquelme, Marta E. ;
Anaya, Juan-Manuel ;
Bae, Sang-Cheol ;
Bang, So-Young ;
Boackle, Susan A. ;
Brown, Elizabeth E. ;
Petri, Michelle A. ;
Gallant, Caroline ;
Ramsey-Goldman, Rosalind ;
Reveille, John D. ;
Vila, Luis M. ;
Criswell, Lindsey A. ;
Edberg, Jeffrey C. ;
Freedman, Barry I. ;
Gregersen, Peter K. ;
Gilkeson, Gary S. ;
Jacob, Chaim O. ;
James, Judith A. ;
Kamen, Diane L. ;
Kimberly, Robert P. ;
Martin, Javier ;
Merrill, Joan T. ;
Niewold, Timothy B. ;
Park, So-Yeon ;
Pons-Estel, Bernardo A. ;
Scofield, R. Hal ;
Stevens, Anne M. ;
Tsao, Betty P. ;
Vyse, Timothy J. ;
Langefeld, Carl D. ;
Harley, John B. ;
Moser, Kathy L. ;
Webb, Carol F. ;
Humphrey, Mary Beth ;
Montgomery, Courtney Gray ;
Gaffney, Patrick M. .
NATURE GENETICS, 2011, 43 (03) :253-U102
[2]   Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations [J].
Bates, J. S. ;
Lessard, C. J. ;
Leon, J. M. ;
Nguyen, T. ;
Battiest, L. J. ;
Rodgers, J. ;
Kaufman, K. M. ;
James, J. A. ;
Gilkeson, G. S. ;
Kelly, J. A. ;
Humphrey, M. B. ;
Harley, J. B. ;
Gray-McGuire, C. ;
Moser, K. L. ;
Gaffney, P. M. .
GENES AND IMMUNITY, 2009, 10 (05) :470-477
[3]   cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination [J].
Bertrand, Mathieu J. M. ;
Milutinovic, Snezana ;
Dickson, Kathleen M. ;
Ho, Wai Chi ;
Boudreault, Alain ;
Durkin, Jon ;
Gillard, John W. ;
Jaquith, James B. ;
Morris, Stephen J. ;
Barker, Philip A. .
MOLECULAR CELL, 2008, 30 (06) :689-700
[4]   Cellular Inhibitors of Apoptosis cIAP1 and cIAP2 Are Required for Innate Immunity Signaling by the Pattern Recognition Receptors NOD1 and NOD2 [J].
Bertrand, Mathieu J. M. ;
Doiron, Karine ;
Labbe, Katherine ;
Korneluk, Robert G. ;
Barker, Philip A. ;
Saleh, Maya .
IMMUNITY, 2009, 30 (06) :789-801
[5]   A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis [J].
Beyaert, R ;
Heyninck, K ;
Van Huffel, S .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1143-1151
[6]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[7]   Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling [J].
Bosanac, Ivan ;
Wertz, Ingrid E. ;
Pan, Borlan ;
Yu, Christine ;
Kusam, Saritha ;
Lam, Cynthia ;
Phu, Lilian ;
Phung, Qui ;
Maurer, Brigitte ;
Arnott, David ;
Kirkpatrick, Donald S. ;
Dixit, Vishva M. ;
Hymowitz, Sarah G. .
MOLECULAR CELL, 2010, 40 (04) :548-557
[8]   A20 in inflammation and autoimmunity [J].
Catrysse, Leen ;
Vereecke, Lars ;
Beyaert, Rudi ;
van Loo, Geert .
TRENDS IN IMMUNOLOGY, 2014, 35 (01) :22-31
[9]   Mechanisms of necroptosis in T cells [J].
Ch'en, Irene L. ;
Tsau, Jennifer S. ;
Molkentin, Jeffery D. ;
Komatsu, Masaaki ;
Hedrick, Stephen M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (04) :633-641
[10]   Nonproteolytic Functions of Ubiquitin in Cell Signaling [J].
Chen, Zhijian J. ;
Sun, Lijun J. .
MOLECULAR CELL, 2009, 33 (03) :275-286